211 related articles for article (PubMed ID: 23055568)
1. Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
O'Connell O; Repik A; Reeves JD; Gonzalez-Perez MP; Quitadamo B; Anton ED; Duenas-Decamp M; Peters P; Lin R; Zolla-Pazner S; Corti D; Wallace A; Wang S; Kong XP; Lu S; Clapham PR
J Virol; 2013 Jan; 87(1):187-98. PubMed ID: 23055568
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Correlates of HIV-1 Macrophage Tropism.
Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
[TBL] [Abstract][Full Text] [Related]
4. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.
Peters PJ; Duenas-Decamp MJ; Sullivan WM; Brown R; Ankghuambom C; Luzuriaga K; Robinson J; Burton DR; Bell J; Simmonds P; Ball J; Clapham PR
Retrovirology; 2008 Jan; 5():5. PubMed ID: 18205925
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
[TBL] [Abstract][Full Text] [Related]
6. Implications of the 375W mutation for HIV-1 tropism and vaccine development.
Verdejo-Torres O; Vargas-Pavia T; Fatima S; Clapham PR; Duenas-Decamp MJ
J Virol; 2024 Jan; 98(1):e0152223. PubMed ID: 38169306
[TBL] [Abstract][Full Text] [Related]
7. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue.
Gonzalez-Perez MP; O'Connell O; Lin R; Sullivan WM; Bell J; Simmonds P; Clapham PR
Retrovirology; 2012 Mar; 9():20. PubMed ID: 22420378
[TBL] [Abstract][Full Text] [Related]
8. Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes.
Duenas-Decamp MJ; Peters PJ; Burton D; Clapham PR
J Virol; 2009 Mar; 83(6):2575-83. PubMed ID: 19129457
[TBL] [Abstract][Full Text] [Related]
9. Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies.
Richards KH; Aasa-Chapman MM; McKnight A; Clapham PR
Retrovirology; 2010 May; 7():48. PubMed ID: 20507591
[TBL] [Abstract][Full Text] [Related]
10. Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes.
Peters PJ; Gonzalez-Perez MP; Musich T; Moore Simas TA; Lin R; Morse AN; Shattock RJ; Derdeyn CA; Clapham PR
Retrovirology; 2015 Jun; 12():48. PubMed ID: 26055104
[TBL] [Abstract][Full Text] [Related]
11. Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.
Zhuang K; Finzi A; Toma J; Frantzell A; Huang W; Sodroski J; Cheng-Mayer C
Retrovirology; 2012 Dec; 9():106. PubMed ID: 23237529
[TBL] [Abstract][Full Text] [Related]
12. Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.
Peters PJ; Sullivan WM; Duenas-Decamp MJ; Bhattacharya J; Ankghuambom C; Brown R; Luzuriaga K; Bell J; Simmonds P; Ball J; Clapham PR
J Virol; 2006 Jul; 80(13):6324-32. PubMed ID: 16775320
[TBL] [Abstract][Full Text] [Related]
13. Viral determinants of HIV-1 macrophage tropism.
Duncan CJ; Sattentau QJ
Viruses; 2011 Nov; 3(11):2255-79. PubMed ID: 22163344
[TBL] [Abstract][Full Text] [Related]
14. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.
Dunfee RL; Thomas ER; Gabuzda D
Retrovirology; 2009 Jul; 6():69. PubMed ID: 19619305
[TBL] [Abstract][Full Text] [Related]
15. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.
Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR
J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768
[TBL] [Abstract][Full Text] [Related]
16. Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues.
Peters PJ; Dueñas-Decamp MJ; Sullivan WM; Clapham PR
J Neuroimmune Pharmacol; 2007 Mar; 2(1):32-41. PubMed ID: 18040824
[TBL] [Abstract][Full Text] [Related]
17. Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.
Ringe R; Thakar M; Bhattacharya J
Retrovirology; 2010 Sep; 7():76. PubMed ID: 20860805
[TBL] [Abstract][Full Text] [Related]
18. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection.
Musich T; Peters PJ; Duenas-Decamp MJ; Gonzalez-Perez MP; Robinson J; Zolla-Pazner S; Ball JK; Luzuriaga K; Clapham PR
J Virol; 2011 Mar; 85(5):2397-405. PubMed ID: 21159865
[TBL] [Abstract][Full Text] [Related]
19. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.
Gonzalez-Perez MP; Peters PJ; O'Connell O; Silva N; Harbison C; Cummings Macri S; Kaliyaperumal S; Luzuriaga K; Clapham PR
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768859
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.
Salimi H; Roche M; Webb N; Gray LR; Chikere K; Sterjovski J; Ellett A; Wesselingh SL; Ramsland PA; Lee B; Churchill MJ; Gorry PR
J Leukoc Biol; 2013 Jan; 93(1):113-26. PubMed ID: 23077246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
